Pharmacovigilance Market - Global Industry Analysis, Size, Share, Growth, Trends and Forecast, Single User License: US $ 4595

Transcription

1 Transparency Market Research Pharmacovigilance Market - Global Industry Analysis, Size, Share, Growth, Trends and Forecast, Single User License: US $ 4595 Buy Now Request Sample Published Date: March 2014 Multi User License: US $ 7595 Corporate User License: US $ Pages Report REPORT DESCRIPTION Pharmacovigilance Market Expected to Reach USD 5.0 Billion Globally in 2019: Transparency Market Research According to a new market report published by Transparency Market Research "Pharmacovigilance Market [Clinical Trial Phases (Pre-Clinical Studies, Phase I, Phase II, Phase III, Phase IV or Post-Marketing Surveillance) and Service Providers (In-House and Contract Outsourcing] - Global Industry Analysis, Size, Share, Growth, Trends and Forecast, ," the global pharmacovigilance market was valued at USD 2,147.3 million in 2012 and is estimated to reach a market worth USD 5,008.2 million in 2019 at a CAGR of 12.9% from 2013 to Browse TOC of Pharmacovigilance Market Report: Rising regulatory concerns, public safety issues, tough inspection regime coupled with instant need of patient reporting has provided the much needed impetus for the pharmacovigilance market. According to World Health Organization (WHO) the pharmacovigilance is defined as the science and activities involved in the detection, assessment, monitoring and evaluation of adverse events or any drug related problems of the medicinal products. The main objective of pharmacovigilance is the safer administration of medicinal products, which is attained through awareness of precise, timely and relevant clinical safety information of medical products.

2 The rapid growth of global pharmaceutical industry has resulted in the innovation in the number of medicinal products that can treat, cure and prevent various disorders. Although, the newly developed products have various benefits, these are allied with number of adverse drug events that can range from mild to severe side effects often resulting in disabilities, illness and death. In order to evade this, early detection of the adverse drug reactions in clinical trials and active clinical phase IV or post-marketing surveillance is imperative to identify these adverse events associate with the products. Nowadays, all the pharmaceutical companies are actively involved in the safety assessment and monitoring of medicinal products which are under clinical trials and also for marketed products. Until recently, the scope of the drug safety reporting was restricted to assessment and monitoring of very small number of medicinal products but now it has been extended to various products such as medical devices, traditional medicines, blood products, vaccines, etc. The guidelines for the appropriate implementation of drug safety reporting services has been formulated by various national and international regulatory authorities such as the World Health Organization (WHO) and United States Food and Drug Administration (USFDA) are aiding in enhancement of the overall PV activities being conducted by the pharmaceutical companies The global market for pharmacovigilance services is segmented based on type of clinical trial phases, service providers and methods used in drug safety reporting. Based on type of clinical trial phases, the market is categorized in to preclinical studies, phase I, II, III, IV or post-marketing surveillance services market. Among these, the market for clinical trial phase IV drug safety reporting services market accounts for the largest market share of 74.7% in 2012 and was valued to USD 1,604.8 million in the same year. This market is expected to lead the pharmacovigilance market till 2019 owing to rise in public safety issues coupled with growing regulatory concerns regarding safety of the marketed products. In addition, the market is segmented based on type of service providers by in-house and contract outsourcing services market. Among these, contract outsourcing pharmacovigilance services market accounts for the largest market share of 50.8% in 2012 and is forecast to grow at a healthy growth rate of 15.5% during the forecast period of 2013 to The contributing factors behind such an assessment include its high cost involvement, quality concerns, requirement of highly qualified professionals and growing regulatory concerns. Geographically, the North American region constituted the largest market for global pharmacovigilance market in 2012; however, Asia-Pacific is predicted to foresee the highest growth rate of 15.2% from 2013 to This growth has been attributed to large population base, low healthcare cost and high enrolment rate of patients. In addition, favorable government support, growing pharmaceutical industry would trigger the growth of this market in Asian-Pacific region.

3 The leading market players include Accenture, Plc, Bristol-Myers Squibb, Covance, Inc., Cognizant Technology Solutions, Icon, Plc.,iGATE Corporation, Novartis International AG, Parexel International Corporation, PRA International, Inc., Pharmaceutical Product Development, Inc. (PPD), Pfizer, Inc., Quintiles Transnational Corporation and Wipro Limited. The global pharmacovigilance market is segmented as follows: Global Pharmacovigilance Market, by Segments Pharmacovigilance Market Type of clinical trial phases Pre-Clinical Studies Phase I Phase II Phase III Phase IV or Post-marketing Surveillance Type of service providers In-House Contract Outsourcing Type of methods used in drug safety reporting Spontaneous reporting Intensified ADR reporting Targeted reporting Cohort event monitoring EHR monitoring Global Life Sciences BPO Market, by Geography North America Europe Asia-Pacific Rest of the World (ROW) TABLE OF CONTENTS Chapter 1 Introduction 1.1 Report Description 1.2 Research Methodology 1.3 Market Segmentation Chapter 2 Executive Summary

4 Chapter 3 Global Pharmacovigilance Market Dynamics 3.1 Introduction Drivers Rise in number of drug consumption Rise in drug toxicity cases producing significant morbidity and mortality Embracing new technologies to mitigate risk Rise in adoption of pharmacovigilance outsourcing services Globalization of drug development with shift from manufacturing activities from high cost to low cost regions Restraints Stringent and varied regulatory approval processes Challenges Lack of availability of skilled labor 3.2 Porter s Five Force Analysis: Global Pharmacovigilance Market Bargaining Power of Suppliers Bargaining Power of Buyers Threat of New Entrants Threat of Substitutes Competitive Rivalry 3.3 Market Attractiveness Analysis of the Global Pharmacovigilance Market, by Geography Market Attractiveness Analysis: Global Pharmacovigilance Market, 2012, by Geography Chapter 4 Global Pharmacovigilance Market, by Clinical Trial Phases 4.1 Overview Preclinical Studies

5 Related & Recently Published Reports by Transparency Market Research Polypropylene Market: Distribution Automation Market: Continuous Glucose Monitoring Market: Global Preclinical Studies Pharmacovigilance Market Revenue, (USD Million) Phase I trial Global Clinical Trial Phase I Pharmacovigilance Market Revenue, (USD Million) Phase II trial Global Clinical Trial Phase II Pharmacovigilance Market Revenue, (USD Million) Phase III trial Global Clinical Trial Phase III Pharmacovigilance Market Revenue, (USD Million) Phase IV trial (Post marketing surveillance) Global Clinical Trial Phase IV Pharmacovigilance Market Revenue, (USD Million) Chapter 5 Global Pharmacovigilance Market, By Type of Methods 5.1 Overview Spontaneous Reporting Global Spontaneous Drug Safety Reporting Market Revenue, (USD Million) Targeted Reporting

6 Global Targeted Drug Safety Reporting Market Revenue, (USD Million) Cohort Event Monitoring Global Cohort Event Monitoring Market Revenue, (USD Million) EHR Monitoring Global Electronic Health Records (EHR) Monitoring Market Revenue, (USD Million) Intensified ADR Reporting Global Intensified ADR Reporting Market Revenue, (USD Million) Chapter 6 Global Pharmacovigilance Market, by Type of Service Providers 6.1 Overview In-House Global In-House Pharmacovigilance Market Revenue, (USD Million) Contract Outsourcing Global Contract Outsourcing Pharmacovigilance Market Revenue, (USD Million) Chapter 7 Global Pharmacovigilance Market, by Geography 7.1 Overview Comparative Analysis: Global Pharmacovigilance Market, by Geography, 2012 & 2019 (Value %) 7.2 North America North America Pharmacovigilance Market Revenue, (USD Million) 7.3 Europe Europe Pharmacovigilance Market Revenue, (USD Million) 7.4 Asia Pacific

7 Browse TOC of Pharmacovigilance Market Report: Asia-Pacific Pharmacovigilance Market Revenue, (USD Million) 7.5 Rest of the World Rest of the World Pharmacovigilance Market Revenue, (USD Million) Chapter 8 Global Pharmacovigilance Market Share Analysis 8.1 Market Share Analysis by Key Players of Global Pharmacovigilance Market Global CRO Market Share Analysis, by Key Players, 2012 (%) Chapter 9 Recommendations 9.1 Success Strategies Developing Strategic Alliances and Partnerships With CROs and Life Science BPOs Companies Hub and Spoke model to optimize drug safety Enhancing operational activities for better outcomes Expand Market into Emerging Countries Chapter 10 Company Profiles 10.1 Accenture, Plc Company Overview Financial Overview Product Portfolio Business Strategies Mergers and acquisitions

8 Recent Developments 10.2 Bristol-Myers Squibb Company Profile Financial overview Product Portfolio Business Strategies Strategic collaboration Research and Development Initiatives Recent Developments 10.3 Clinquest Group B.V Company Overview Product Portfolio Business Strategies Strategic partnership Recent Developments 10.4 Cognizant Technology Solutions Company Overview Financial Overview Product Portfolio Business Strategies Expansion of geographical footprint Expansion of product portfolio Highly-skilled manpower Strategic acquisitions Recent Developments

9 10.5 Covance, Inc Company Overview Financial Overview Product Portfolio Business Strategies New product development and innovation Agreements and collaborations Strategic acquisitions Geographical expansion of business Recent Developments 10.6 GlaxoSmithKline (GSK) Company Overview Financial overview Product Portfolio Business strategies Research and development initiatives Direct to Consumer Advertising Mergers and acquisitions Recent developments 10.7 ICON, Plc Company Overview Financial Overview Product Portfolio Business Strategies Business expansion in APAC region

10 Browse TOC of Pharmacovigilance Market Report: Expansion of services offered Recent Developments 10.8 igate Corporation Company Overview Financial Overview Product Portfolio Business Strategies Strategic Acquisition Recent Developments 10.9 imedglobal Corporation Company Overview Product Portfolio Business Strategies Geographical Expansion Recent Developments Infosys Company Overview Financial Overview Product Portfolio Business Strategies Extensive product portfolio Geographical expansion of business Recent Developments

11 10.11 inventiv Health Inc Company Overview Product Portfolio Business Strategies Strategic Partnership Strategic Acquisition Recent Developments Johnson and Johnson Company Profile Financial Overview Product Portfolio Business Strategies Extensive Research and Development Investments Strategic Collaborative Arrangements Recent Developments Novartis International AG Company Overview Financial Overview Product Portfolio Business Strategy Mergers and Acquisitions Recent Developments OptumInsight, Inc Company Overview Product Portfolio

12 Business Strategies Strategic product launch Strategic collaboration Recent Developments Parexel International Corporation Company Overview Financial Overview Product Portfolio Strong presence in Asia and emerging markets Strategic alliances Mergers & Acquisitions Recent Developments Pfizer, Inc Company Overview Financial Overview Product Portfolio Business Strategies Acquisitions Recent Developments Pharmaceutical Product Development, Inc. (PPD, Inc.) Company Overview Product Portfolio Business Strategies Expanding geographic presence Incorporation of innovative technologies

13 Strategic acquisitions New product launch and innovation Recent Developments PRA International, Inc Company Overview Product Portfolio Business Strategies Mergers and acquisitions Recent Developments Quantum Solutions India Company Overview Product Portfolio Business Strategies Strategic Collaborations Quintiles Transnational Corporation Company Overview Financial Overview Product Portfolio Business Strategies Expansion of services Acquisitions and partnerships Innovation in services offered Recent Developments F. Hoffmann-La Roche Ltd Company Overview

14 Financial Overview Product Portfolio Business Strategies Licensing Agreement Product portfolio expansion Sanofi Aventis Company Overview Financial Overview Product Portfolio Business Strategy Renewal of cooperation protocol Recent developments Synowledge LLC Company Overview Product Portfolio Business Strategies Geographical Expansion Strategic Partnership Recent Developments United BioSource Corporation Company Overview Product Profiling Business Strategies Strategic acquisitions Wipro Limited

15 Browse TOC of Pharmacovigilance Market Report: Company Overview Financial Overview Product Portfolio Business Strategies Geographical expansion About Us: Transparency Market Research is a market intelligence company providing global business information reports and services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insight for thousands of decision makers. We are privileged with highly experienced team of Analysts, Researchers and Consultants, who use proprietary data sources and various tools and techniques to gather, and analyze information. Our business offerings represent the latest and the most reliable information indispensable for businesses to sustain a competitive edge. Contact: Transparency Market Research 90 State Street, Suite 700, Albany NY United States Tel: USA - Canada Toll Free sales@transparencymarketresearch.com Website: Related Blogs: